Turkey Tail Mushroom for Cancer Risk Reduction

Research suggests that Turkey Tail mushroom extracts, particularly the compound PSK and preparations derived from Coriolus versicolor, have shown some promising signals in cancer-related research, though the overall evidence remains limited and mixed. One randomized controlled trial found that a Coriolus versicolor-based vaginal gel helped resolve HPV-related cervical cell abnormalities and promoted HPV clearance more effectively than watchful waiting, which is relevant given HPV's role in cervical cancer risk. A Cochrane systematic review of seven randomized controlled trials examined PSK as an adjunct to standard colorectal cancer treatment and found only very low certainty evidence regarding side effect reduction and low certainty evidence of a modest survival benefit, with the authors noting that the outdated chemotherapy regimens used in those studies make the findings difficult to apply to current practice. Taken together, the available studies are too limited in number, scope, and certainty to draw firm conclusions, and individuals with cancer-related concerns should consult a qualified healthcare provider rather than relying on this research alone to guide decisions.